Literature DB >> 26137230

Association between the polymorphisms of the vascular endothelial growth factor gene and metabolic syndrome.

Young Ree Kim1, Seung-Ho Hong2.   

Abstract

Vascular endothelial growth factor (VEGF) is a major angiogenic factor. Increased levels of VEGF have been reported in patients with metabolic syndrome (MetS). The role of VEGF polymorphisms in MetS susceptibility, however, has not been reported previously. Thus, the present study was performed to analyze the associations between the VEGF -634G>C and 936C>T polymorphisms and the patients with MetS. A total of 320 patients with MetS (mean age, 49.86±11.76 years) and 320 healthy subjects (mean age, 50.94±8.43 years) were enrolled in the study. The VEGF -634G>C polymorphism in the 5'-untranslated region (UTR) and 936C>T polymorphism in 3'-UTR were analyzed by polymerase chain reaction-restriction fragment length polymorphism. The VEGF -634G>C polymorphism significantly affected MetS susceptibility. The CC genotype of the -634G>C polymorphism was significantly associated with an increased risk of MetS [adjusted odds ratio (AOR)=3.973; 95% confidence interval (CI), 2.321-6.799; P<0.0001]. AORs of the dominant (GG vs. GC+CC) and recessive models (GG+GC vs. CC) between the cases and controls were 2.569 (95% CI, 1.657-3.983; P<0.0001) and 2.163 (95% CI, 1.475-3.171; P=0.0001), respectively. Haplotypes of -634G>C and 936C>T were also associated with MetS susceptibility. When the haplotype data were stratified by gender, the association remained only in males. The -634G>C polymorphism was also associated with the subgroups of MetS risk components by the stratification analysis. The 936C>T polymorphism was, however, not associated with the MetS susceptibility. The present study demonstrates that the VEGF -634G>C polymorphism and haplotypes may be a genetic determinant for the MetS susceptibility. To the best of our knowledge, this is the first study on the significant association of the VEGF polymorphisms in MetS patients. To confirm the effects of the VEGF polymorphisms on MetS, further functional and population studies are required.

Entities:  

Keywords:  VEGF; metabolic syndrome; polymorphism

Year:  2015        PMID: 26137230      PMCID: PMC4461858          DOI: 10.3892/br.2015.423

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  47 in total

1.  The role of vascular endothelial growth factor +405 G/C polymorphism and albuminuria in patients with type 2 diabetes mellitus.

Authors:  Abdolrahim Nikzamir; Alireza Esteghamati; Amir Abbas Hammedian; Touraj Mahmoudi
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

2.  Polymorphisms of VEGF, TGFβ1, TGFβR2 and conotruncal heart defects in a Chinese population.

Authors:  Enshi Wang; Zhenhua Wang; Shenghua Liu; Haiyong Gu; Dingxu Gong; Kun Hua; Yu Nie; Jue Wang; Haoran Wang; Jie Gong; YuJian Zhang; Hui Zhang; Ruiping Liu; Shengshou Hu; Hao Zhang
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

3.  Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients.

Authors:  L Rodríguez-Rodríguez; M García-Bermúdez; C González-Juanatey; T R Vazquez-Rodriguez; J A Miranda-Filloy; B Fernández-Gutierrez; J Llorca; J Martín; M A González-Gay
Journal:  Tissue Antigens       Date:  2011-04

4.  A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.

Authors:  Takuya Awata; Kiyoaki Inoue; Susumu Kurihara; Tomoko Ohkubo; Masaki Watanabe; Kouichi Inukai; Ikuo Inoue; Shigehiro Katayama
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

5.  Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance.

Authors:  Hiromichi Wada; Noriko Satoh; Shuji Kitaoka; Koh Ono; Tatsuya Morimoto; Teruhisa Kawamura; Tameo Nakano; Masatoshi Fujita; Toru Kita; Akira Shimatsu; Koji Hasegawa
Journal:  Atherosclerosis       Date:  2009-07-30       Impact factor: 5.162

6.  Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation.

Authors:  Tuomas Tammela; Georgia Zarkada; Elisabet Wallgard; Aino Murtomäki; Steven Suchting; Maria Wirzenius; Marika Waltari; Mats Hellström; Tibor Schomber; Reetta Peltonen; Catarina Freitas; Antonio Duarte; Helena Isoniemi; Pirjo Laakkonen; Gerhard Christofori; Seppo Ylä-Herttuala; Masabumi Shibuya; Bronislaw Pytowski; Anne Eichmann; Christer Betsholtz; Kari Alitalo
Journal:  Nature       Date:  2008-06-25       Impact factor: 49.962

7.  Association of VEGF gene polymorphisms with diabetic retinopathy in a south Indian cohort.

Authors:  Satagopan Uthra; Rajiv Raman; Bickol N Mukesh; Samuel A Rajkumar; Kumari R Padmaja; Pradeep G Paul; Praveena Lakshmipathy; Perumal Gnanamoorthy; Tarun Sharma; Catherine A McCarty; Govindasamy Kumaramanickavel
Journal:  Ophthalmic Genet       Date:  2008-03       Impact factor: 1.803

8.  Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndrome.

Authors:  Marcin Barylski; Edward Kowalczyk; Maciej Banach; Julita Ciecwierz; Lucjan Pawlicki; Jan Kowalski
Journal:  Angiology       Date:  2008-11-17       Impact factor: 3.619

9.  Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction.

Authors:  Panagiotis Douvaras; Dionisios G Antonatos; Kiriaki Kekou; Sotirios Patsilinakos; George Chouliaras; Apostolos Christou; Anastasios Andrikou; Emmanuel Kanavakis
Journal:  Cardiology       Date:  2009-03-31       Impact factor: 1.869

10.  Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.

Authors:  Mojca Globocnik Petrovic; Peter Korosec; Mitja Kosnik; Josko Osredkar; Marko Hawlina; Borut Peterlin; Daniel Petrovic
Journal:  Mol Vis       Date:  2008-07-30       Impact factor: 2.367

View more
  7 in total

1.  Genetic association between miR-27a and miR-449b polymorphisms and susceptibility to diabetes mellitus.

Authors:  Youngmi Choi; Seung-Ho Hong
Journal:  Biomed Rep       Date:  2022-03-02

2.  Promoter polymorphisms of the vascular endothelial growth factor gene are associated with metabolic syndrome susceptibility in Koreans.

Authors:  Young Ree Kim; Seung-Ho Hong
Journal:  Biomed Rep       Date:  2017-04-07

3.  Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of non-small cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways.

Authors:  Jie Li; Fang Liu; Shulong Jiang; Jie Liu; Xiuhong Chen; Shangnuan Zhang; Haibo Zhao
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

4.  Association of vascular endothelial growth factor expression and polymorphisms with the risk of gestational diabetes mellitus.

Authors:  Ping-Ping Dong
Journal:  J Clin Lab Anal       Date:  2018-10-23       Impact factor: 2.352

5.  Association between VEGF Gene Polymorphisms and In-Stent Restenosis after Coronary Intervention Treated with Bare Metal Stent.

Authors:  Zsolt Bagyura; Loretta Kiss; Kristóf Hirschberg; Balázs Berta; Gábor Széplaki; Árpád Lux; Zsolt Szelid; Pál Soós; Béla Merkely
Journal:  Dis Markers       Date:  2017-03-07       Impact factor: 3.434

6.  Early anticoagulation therapy for severe burns complicated by inhalation injury in a rabbit model.

Authors:  Zhong-Hua Fu; Guang-Hua Guo; Zhen-Fang Xiong; Xincheng Liao; Ming-Zhuo Liu; Jinhua Luo
Journal:  Mol Med Rep       Date:  2017-09-20       Impact factor: 2.952

Review 7.  Deep Insight of the Pathophysiology of Gestational Diabetes Mellitus.

Authors:  Amarish Kumar Sharma; Sanjeev Singh; Himanshu Singh; Deviyani Mahajan; Prachetha Kolli; Gowtham Mandadapu; Bimlesh Kumar; Dharmendra Kumar; Sudarshan Kumar; Manoj Kumar Jena
Journal:  Cells       Date:  2022-08-28       Impact factor: 7.666

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.